ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.
ETFOptimize | HOME
Close Window
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens

By: Newsfile

Cranford, New Jersey--(Newsfile Corp. - May 19, 2023) - WBB Research Institute (WBBRI) hosted a Demi-Colton Virtual Salon on the need for a global response to Candida auris and other deadly pathogens. Antimicrobial resistant C. auris is becoming a major public health threat and is found in over 30 countries causing outbreaks in hospitals, nursing homes, and other healthcare settings. It or another emerging antimicrobial resistant pathogen will likely be the cause of the next global pandemic. Scynexis (NASDAQ: SCYX) and T2 Biosystems (NASDAQ: TTOO) were two of the public companies that participated in the webinar, which highlighted the need for increased collaboration between academia, government agencies and the private sector to accelerate the development and use of rapid blood diagnostics and novel therapeutics.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Antimicrobial resistant C. auris is becoming a major public health threat
  • The webinar highlighted the need for increased collaboration between academia, government agencies and the private sector.
  • To accelerate the use of rapid from whole blood diagnostics and novel therapeutics.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/166755_figure1_550.jpg

Click image above to view full announcement.

WBB Securities
The WBB Research Institute is a research organization, founded by WBB Securities. The Institute focuses on emerging critical issues in healthcare that threaten to have profound impact. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused on the life sciences. WBB Securities is registered with the SEC as a broker-dealer, a FINRA member firm, and a Registered Investment Advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

Demy-Colton
Demy Colton is a leader in biotech and life science events, with over 20 years of experience connecting leaders of innovative biotech companies with key stakeholders, investors, and advisors, we create ideal environments to examine and address opportunities and challenges in today's biotech industry.www.demy-colton.com.

Contacts:

Fatima Bohorquez
(908) 518 7610
Fatima.Bohorquez@wbbsec.com

Source: WBB Securities

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/166755

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.51
+1.11 (0.45%)
AAPL  275.40
+5.97 (2.22%)
AMD  239.66
-4.32 (-1.77%)
BAC  53.81
+0.39 (0.74%)
GOOG  290.80
+0.21 (0.07%)
META  625.09
-6.67 (-1.06%)
MSFT  509.13
+3.13 (0.62%)
NVDA  194.00
-5.05 (-2.54%)
ORCL  234.34
-6.49 (-2.69%)
TSLA  437.45
-7.78 (-1.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.


 
IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.